Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Sep, 21 2025
Jan, 8 2026
Dec, 18 2025
Dec, 17 2025
Nov, 1 2025